Newbridge Financial Services Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.3K | Buy |
95
+2
| +2% | +$807 | 0.01% | 561 |
|
|
2025
Q1 | $46.5K | Sell |
93
-7
| -7% | -$3.5K | 0.01% | 380 |
|
|
2024
Q4 | $52.2K | Buy |
+100
| New | +$52.2K | 0.01% | 395 |
|
|
2024
Q3 | – | Sell |
-64
| Closed | -$35.6K | – | 1075 |
|
|
2024
Q2 | $35.6K | Sell |
64
-58
| -48% | -$32.3K | 0.01% | 452 |
|
|
2024
Q1 | $71.1K | Sell |
122
-1,167
| -91% | -$680K | 0.03% | 336 |
|
|
2023
Q4 | $684K | Sell |
1,289
-16
| -1% | -$8.49K | 0.33% | 72 |
|
|
2023
Q3 | $660K | Buy |
1,305
+16
| +1% | +$8.1K | 0.33% | 58 |
|
|
2023
Q2 | $672K | Sell |
1,289
-31
| -2% | -$16.2K | 0.33% | 57 |
|
|
2023
Q1 | $761K | Sell |
1,320
-21
| -2% | -$12.1K | 0.4% | 48 |
|
|
2022
Q4 | $739K | Buy |
1,341
+120
| +10% | +$66.1K | 0.43% | 47 |
|
|
2022
Q3 | $619K | Buy |
1,221
+9
| +0.7% | +$4.56K | 0.36% | 59 |
|
|
2022
Q2 | $659K | Sell |
1,212
-15
| -1% | -$8.16K | 0.41% | 51 |
|
|
2022
Q1 | $725K | Buy |
1,227
+52
| +4% | +$30.7K | 0.36% | 55 |
|
|
2021
Q4 | $784K | Buy |
1,175
+1,109
| +1,680% | +$740K | 0.37% | 55 |
|
|
2021
Q3 | $38K | Hold |
66
| – | – | 0.02% | 492 |
|
|
2021
Q2 | $33K | Buy |
66
+4
| +6% | +$2K | 0.02% | 582 |
|
|
2021
Q1 | $28K | Buy |
62
+39
| +170% | +$17.6K | 0.02% | 601 |
|
|
2020
Q4 | $11K | Hold |
23
| – | – | 0.01% | 707 |
|
|
2020
Q3 | $10K | Buy |
+23
| New | +$10K | 0.01% | 679 |
|